John Mendlein
CIK: 0001238362
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FATE
FATE THERAPEUTICS INC
Director
Discretionary Trading P&L
Holdings
About MENDLEIN JOHN
MENDLEIN JOHN (SEC CIK 0001238362) files insider reports with the SEC as Director of FATE THERAPEUTICS INC (FATE).
Signal8 holds 1 ownership filing by MENDLEIN JOHN, a Form 4, filed on May 30, 2025. Those filings report 1 transaction, the latest on May 29, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on MENDLEIN JOHN's filings is in SAN DIEGO, CA.
Recent filings by MENDLEIN JOHN
- May 29, 2025: Grant or award of FATE derivative securities (Form 4, code A).
Other insiders filing for FATE THERAPEUTICS INC (FATE)
- TAHL CINDY
- Valamehr Bahram, President and CEO
- Redmile Group, LLC, Director
- Lee Michael Stewart, Director
- Xu Yuan, Director
- Jooss Karin, Director